معرفی
Martin Bergram is a researcher at Linköping University's Department of Health, Medicine and Caring Sciences within the Faculty of Medicine and Health Sciences, operating through the Division of Prevention, Rehabilitation and Community Medicine and Unit of Clinical Medicine. His work centers on Metabolic Associated Steatotic Liver Disease (MASLD) in diabetes management within primary care settings.
His academic credentials include:
- Medical Doctor degree from Linköping University (2011)
- Specialist in General Practice certification (2021)
- PhD candidacy since 2020
Bergram's research examines MASLD prevalence in primary care, current management protocols, cost-effective screening implementation, and connections between MASLD and microvascular diabetes complications. His interdisciplinary approach integrates hepatology, epidemiology, and health economics to address gaps in liver disease diagnosis and resource allocation within Swedish primary healthcare systems.
Analysis of his 2022-2025 publications reveals consistent epidemiological investigation of MASLD in type 2 diabetes populations, with emphasis on biomarker validation (Activin A, PNPLA3 variants), fibrosis assessment, and awareness deficits among clinicians. His work demonstrates methodological progression from observational studies toward cost-effectiveness modeling for screening programs.
As an active clinical educator, Bergram supervises medical students and junior doctors while collaborating with senior researchers including Karin Rådholm and Mattias Ekstedt. He contributes to the EPSOMiP project investigating fatty liver-epicardial fat-cardiovascular disease relationships in diabetic patients and participates in the National Research School in General Practice at Umeå University.
